Company · CIK 0001637715 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
OnKure Therapeutics, Inc. · OKUR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 SForm 4 → | Sep 23, 4:54 pm EDT | Nicholas A SaccomanoPresident and CEO, Director | 87 | $2.97 | $259 | 11,160 | −0.77% | |
| Sep 21, 2026 SForm 4 → | Sep 23, 4:52 pm EDT | Jason A. LeveroneChief Financial Officer | 302 | $2.97 | $898 | 18,500 | −1.61% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.